CBIO vs VSTM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

CBIO

45.5
AI Score
VS
VSTM Wins

VSTM

48.3
AI Score

Investment Advisor Scores

CBIO

46score
Recommendation
HOLD

VSTM

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO VSTM Winner
Revenue 1.04M 10.00M VSTM
Net Income -48.12M -8.26M VSTM
Net Margin -4631.4% -82.6% VSTM
Operating Income -51.09M -46.34M VSTM
ROE -29.5% -43.8% CBIO
ROA -26.3% -7.8% VSTM
Total Assets 182.76M 105.75M CBIO
Cash 171.59M 83.37M CBIO
Current Ratio 9.66 3.28 CBIO
Free Cash Flow -28.56M -55.91M CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: -8.9% · 3M: -13.8% VSTM 1M: +29.1% · 3M: -3.2%

Current Technical Phase

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.8%), weak momentum, RSI 45

RSI (14): 45.0 · Price: $15.45

VSTM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.2% over 20 days), RSI 56

RSI (14): 56.2 · Price: $5.76

Fundamentals Snapshot

Metric CBIO VSTM
Market Cap
Forward P/E -5.7 -4.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.8%
Gross Margin 1.0% 0.9%
Operating Margin -14.3% -2.4%
EPS -0.14 -2.52
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, VSTM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.